The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Knight Therapeutics Inc down $0.03

Knight Therapeutics Inc is lower today, dropping $0.03 or 0.43% to $6.98. Shares have lost 0.99% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P TSX by 25.86% during the last year.

Key company metrics

  • Trailing P/E4.00×
  • P/E 1 year forward77.89×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$1.74
Updated May 22 1:22 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3210
Selling / general / administrative2110
Research & development0100
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total000--
Operating income-2-200
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets129------
Income before tax130100
Income after tax125100
Income tax, total5000
Net income125100
Total adjustments to net income--------
Net income before extra. items125100
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items125100
Inc. avail. to common incl. extra. items125100
Diluted net income125100
Dilution adjustment------0
Diluted weighted average shares7978638
Diluted EPS excluding extraordinary itemsvalue per share1.570.010.01-0.01
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share0.010.010.01-0.01